{"id":"W2330334958","doi":"10.1097/01.cot.0000410634.85197.4e","title":"Prostate Cancer: New MET, VEGFR Inhibitor Produces Impressive Response in Bone","year":2011,"lang":"en","type":"article","venue":"Oncology Times","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Cabozantinib; Medicine; Prostate cancer; Cancer; Oncology; Internal medicine; Docetaxel; Discontinuation; Prostate","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009050196,0.000493532,0.0002995806,0.0002965423,0.0003999681,0.0007778514,0.0002274383,0.0008584305,0.003331573],"category_scores_gemma":[0.0005155703,0.000200139,0.0003947419,0.0001359259,0.0002849803,0.0003481703,0.0002429376,0.001997376,0.0009510706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008390393,"about_ca_system_score_gemma":0.0005922596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001739896,"about_ca_topic_score_gemma":0.01171815,"domain_scores_codex":[0.9997633,0.00004601356,0.0000154489,0.00003555326,0.00009598138,0.00004366909],"domain_scores_gemma":[0.9997572,0.00004274299,0.00001621752,0.00001054585,0.0000677317,0.0001056264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003456729,0.001026322,0.005536703,0.0003989895,0.0001431279,0.001445407,0.0002536786,0.000203333,0.03736199,0.001562293,0.6540374,0.294574],"study_design_scores_gemma":[0.004696114,0.00757258,0.02926857,0.0002073742,0.0002540518,0.004987311,0.0002039692,0.001001243,0.01903961,0.0007449516,0.9319409,0.00008338469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.3113336,0.1737534,0.003110093,0.3816515,0.05232747,0.0007325215,0.001666856,0.001458407,0.07396619],"genre_scores_gemma":[0.6029066,0.0787992,0.004958087,0.1166857,0.02852147,0.0003862931,0.003013966,0.0002394585,0.1644893],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.003331573,"threshold_uncertainty_score":0.01114523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04097261889894682,"score_gpt":0.3572448530971525,"score_spread":0.3162722341982057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}